Errors exist on this page. Correct the errors and resubmit the form.

    National Vision Holdings, Inc. Reports Second Quarter 2020 Financial Results

    • Net revenue decreased5% to $260.0 million
    • Negative comparable store sales growth of (44.7)%; Adjusted Comparable Store Sales Growth of (36.5)%
    • For June, comparable store sales growth of 14.3% and Adjusted Comparable Stores Sales Growth of 19.3%
    • Net loss of $(43.8) million; Diluted EPS of $(0.55)
    • Adjusted EBITDA of $(14.4) million
    • Adjusted Operating Income of $(34.4) million
    • Adjusted Diluted EPS of $(0.41)
    • Extended partnership with Walmart Inc. for three years

     

    Duluth, Ga. -- August 6, 2020 -- National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the second quarter ended June 27, 2020.

    “The second quarter represented one of the most eventful periods in our Company's history and our respective careers,” stated Reade Fahs, chief executive officer. “Following our March closings, we are pleased to have safely reopened our stores by early June. With our many new protocols in place, we believe we have an effective, safety first approach to serve patients and customers in a COVID-19 environment. While we expect the macro environment will continue to evolve, we believe we are well positioned to continue operations throughout the remainder of the COVID-19 pandemic.”

    Mr. Fahs further commented, “Since reopening, our stores have experienced consistently strong demand from our patients and customers. June comps increased over 19%, the best reported comp increase in my 18 years at National Vision, with similar momentum continuing throughout July. Results were likely helped by pent-up demand during the lock-down and benefits from government stimulus payments. But performance also reflects successful macro and micro navigation of this dynamic situation by our operations and product teams. As our stores provide essential healthcare services and products, and given the state of the economy, we believe ever more consumers are drawn to our affordably priced eye exams, eyeglasses, and contact lenses.”

    Mr. Fahs continued, “In May, we took the financial steps to strengthen our balance sheet and are confident in our financial flexibility and liquidity to navigate the remainder of the pandemic. In July, we were pleased to extend our 30-year partnership with Walmart for another three years into 2024. This contract extension comes on the heels of the successful transition of the five additional Vision Centers that Walmart granted in January. We have been encouraged by the initial results at these stores to date and see tremendous future potential for them as well.”

    Mr. Fahs concluded, “As matters of diversity and inclusion are ever more on the minds of both consumers and associates, especially relative to the Black community, they remain a priority at National Vision as we strive to be an ever more inclusive workplace. In the second quarter, we established a Diversity, Equity and Inclusion Council to give a stronger voice to our Black associates and other minorities within the National Vision family. And, as we continue to strive to provide a life-giving culture for our associates and doctors who practice alongside our stores, we made investments in our people including a one-time $250 ‘appreciation’ bonus to our front line associates and network of doctors for their exceptional work under difficult circumstances over the past several months. I derive constant inspiration by the work and determination of the extended National Vision team. While there remains uncertainty about the future, I am confident that we will emerge stronger and better from this extraordinary experience.”

    Adjusted Comparable Store Sales Growth, Adjusted EBITDA, Adjusted Operating Income, Adjusted Diluted EPS, Adjusted Operating Margin, Adjusted EBITDA Margin, and EBITDA are not measures recognized under generally accepted accounting principles (“GAAP”). Please see “Non-GAAP Financial Measures” and “Reconciliation of Non-GAAP to GAAP Financial Measures” below for more information.

    COVID-19 Response Update

    The Company continues to take actions to manage its business through the dynamic and challenging environment resulting from the COVID-19 pandemic.  Following temporary store closures to the public in March 2020, the Company completed the process of reopening stores with enhanced safety and cleaning protocols in early June 2020. In addition, the Company continues to take actions to manage the business that the Company believes are prudent in these circumstances, including:

    • In May 2020, the Company completed the issuance of $402.5 million aggregate principal amount of 2.50% convertible senior notes due 2025;
    • In May 2020, the Company and the lenders under its credit facility entered into an amendment to the facility. This amendment is intended to prevent the effects of the COVID-19 pandemic, including the temporary closure of stores, from creating uncertainty relative to the Company’s ability to comply with certain financial covenants and allow it to focus on prudent management of the business over the quarters ahead. The amendment suspends certain financial maintenance covenants contained in the facility until testing at the end of the second fiscal quarter of 2021;
    • In connection with the reopening to the public of its retail stores, the Company returned to previous levels of compensation and work hours across the organization, and the respective base salaries of executive officers were reinstated to pre-COVID-19 levels effective as of June 7, 2020;
    • In May 2020, the Company resumed unit growth and expects to open between 50 and 55 new stores in 2020. In addition to new store openings, as previously announced, the Company transitioned five additional Vision Centers in Walmart stores to its management during the second quarter of 2020; and
    • The Company recorded a credit of $10.8 million as a reduction of costs applicable to revenue and selling, general and administrative expenses ("SG&A") as a result of the employee retention credits made available under the Coronavirus Aid, Relief and Economic Security Act (CARES Act).

    Given the uncertainties, dynamic nature, resurgence, and unknown duration of the pandemic, the Company is continuing to evaluate additional operational and financial measures that may be taken as the Company continues to respond to the impact of COVID-19 on its business.

    Second Quarter 2020 Summary

    • Net revenue decreased 5% to $260.0 million from $429.5 million for the second quarter of 2019.
    • Net revenue was negatively impacted by 0% due to the timing of unearned revenue, which also resulted in material impacts to profitability. The Company experienced an increase in unearned revenue of $34.4 million in the second quarter compared to a decrease in unearned revenue of $8.5 million for the same period of 2019. The increase in unearned revenue resulted from the temporary store closures at the end of the first quarter of 2020 as well as stronger sales at the end of the second quarter of 2020.
    • Comparable store sales growth was (44.7)% and Adjusted Comparable Store Sales Growth was (36.5)%.
    • In light of the temporary store closures, the Company is providing certain additional comparable store sales growth information. For the respective months ended April 25, 2020, May 30, 2020, and June 27, 2020:
      • Comparable store sales growth was (83.9)%, (56.6)% and 14.3%; and
      • Adjusted Comparable Store Sales Growth was (86.6)%, (38.5)% and 19.3%.
    • The Company opened 12 new stores, transitioned five Vision Centers in Walmart stores to its management, closed five stores, and ended the quarter with 1,185 stores. Overall, store count grew 5.1% from June 29, 2019 to June 27, 2020.
    • Costs applicable to revenue decreased 30.5% to $140.8 million from $202.5 million for the second quarter of 2019. As a percentage of net revenue, costs applicable to revenue increased 690 basis points to 54.1% from 47.2% for the second quarter of 2019. This increase as a percentage of net revenue was primarily driven by optometrist costs incurred during store closures and increased contact lens mix.
    • SG&A decreased 25.1% to $136.6 million from $182.3 million for the second quarter of 2019. As a percentage of net revenue, SG&A increased 1,010 basis points to 52.5% from 4% for the second quarter of 2019. This increase as a percentage of net revenue was primarily driven by store and corporate payroll and occupancy costs incurred during store closures, partially offset by lower advertising investment. SG&A for the second quarter of 2020 includes $2.5 million of incremental costs directly related to adapting the Company's operations during the COVID-19 pandemic.
    • Net income decreased 527% to a net loss of $43.8 million compared to net income of $10.3 million for the second quarter of 2019.
    • Diluted earnings (loss) per share decreased 533% to $(0.55) compared to $0.13 for the second quarter of 2019. Adjusted Diluted EPS decreased 325% to $(0.41) compared to $0.18 for the second quarter of 2019. The net change in margin on unearned revenue negatively impacted Adjusted Diluted EPS by $(0.30).
    • Adjusted EBITDA decreased 130% to $(14.4) millioncompared to $48.1 million for the second quarter of 2019. Adjusted EBITDA Margin decreased 1,670 basis points to (5.5)% from 11.2% for the second quarter of 2019.
    • Adjusted Operating Income decreased 218% to $(34.4) million compared to $29.1 million for the second quarter of 2019. Adjusted Operating Margin decreased 2,000 basis points to (13.2)% from 6.8% for the second quarter of 2019. The net change in margin on unearned revenue negatively impacted Adjusted EBITDA and Adjusted Operating Income by $(32.5) million.

    Six-Month Period Highlights

    • Net revenue decreased 18.1% to $729.7 million from $890.7 million for the same period of 2019.
    • Net revenue was negatively impacted by 7% due to the timing of unearned revenue.
    • Comparable store sales growth was (23.0)% and Adjusted Comparable Store Sales Growth was (22.6)%.
    • The Company opened 35 new stores, transitioned five Vision Centers in Walmart stores to its management, closed six stores, and ended the period with 1,185 stores.
    • Costs applicable to revenue decreased 13.3% to $359.3 million from $414.5 million for the same period of 2019. As a percentage of net revenue, costs applicable to revenue increased 270 basis points to 2% from 46.5% for the same period of 2019. This increase as a percentage of net revenue was primarily driven by optometrist costs incurred during store closures as well as increased contact lens mix, partially offset by higher eyeglass margin.
    • SG&A decreased 12.2% to $330.3 million from $376.2 million for the same period of 2019. As a percentage of net revenue, SG&A increased 310 basis points to 45.3% from 42.2% for the same period of 2019. This increase as a percentage of net revenue was primarily driven by store and corporate payroll and occupancy expense, partially offset by lower advertising investment. SG&A for the first six months of 2020 includes $3.1 million of incremental costs directly related to adapting the Company's operations during the COVID-19 pandemic.
    • Net income decreased 223% to a net loss of $34.1 million compared to net income of $27.7 million for the same period of 2019.
    • Diluted earnings (loss) per share decreased 225% to $(0.42) compared to $0.34 for the same period of 2019. Adjusted Diluted EPS decreased 126% to $(0.13) compared to $0.49 for the same period of 2019. The net change in margin on unearned revenue negatively impacted Adjusted Diluted EPS by $(0.11).
    • Adjusted EBITDA decreased 57.3% to $46.7 millioncompared to $109.3 million for the same period of 2019. Adjusted EBITDA Margin decreased 590 basis points to 6.4% from 12.3% for the same period of 2019.
    • Adjusted Operating Income decreased 94.9% to $3.6 million compared to $71.7 million for the same period of 2019. Adjusted Operating Margin decreased 760 basis points to 0.5% from 8.1% for the same period of 2019. The net change in margin on unearned revenue negatively impacted Adjusted EBITDA and Adjusted Operating Income by $(11.9) million.

    Balance Sheet and Cash Flow Highlights as of June 27, 2020

    • The Company’s cash balance was $256.3 million as of June 27, 2020. The Company had no borrowings under its $300.0 million first lien revolving credit facility, exclusive of letters of credit of $5.7 million.
    • Total debt was$648.2 million as of June 27, 2020, consisting of outstanding first lien term loans, convertible senior notes and finance lease obligations, net of unamortized discounts.
    • As noted above, in May 2020, the Company completed the issuance of $402.5 million aggregate principal amount of 2.50% convertible senior notes due 2025. The Company received proceeds from the offering of $390.9 million, net of underwriting fees and other issuance costs. The Company used $294.3 million of the net proceeds to repay the full amount outstanding under the revolving credit facility and $75.0 million to partially repay the term loans.
    • Cash flows from operating activities for first six months of 2020 were $71.4 million compared to $119.3 million for the same period of 2019.
    • Capital expenditures for the first six months of 2020 totaled $25.8 million compared to $52.1 million for the same period of 2019, primarily due to the postponement of capital projects.
    • The Company believes it has sufficient liquidity to fund operations for at least the next 12 months, given cash on hand, cash expected to be generated from operations, and the cash available through its revolving credit facility.

    Recent Developments

    • In July, the Company granted a one-time $250 cash bonus to front-line associates and the Company's network of doctors in recognition of their hard work and dedication toward safely serving patients and customers.
    • In July, the Company entered into an amendment to its existing Management & Services Agreement ("MSA") with Walmart Inc. that extended the current term and economics of the MSA by three years to February 23, 2024.


    Fiscal 2020 Outlook

    As previously disclosed, given the uncertainty surrounding the magnitude and duration of the COVID-19 pandemic, the Company withdrew its fiscal 2020 outlook on March 27, 2020 and is not providing an earnings outlook at this time. However, the Company is providing the following updated assumptions for fiscal 2020:

    New Stores

    50 - 55 New Stores

    Depreciation and Amortization1

    $94 - $95 million

    Interest2

    $33 - $34 million

    Capital Expenditures

    $65 - $75 million

    Incremental COVID-19 Expenses

    ~$8 million

     

     

    1 - Includes amortization of acquisition intangibles of approximately $7.4 million
    2 - Before the impact of gains or losses related to hedge ineffectiveness and charges related to interest payments and amortization of debt discounts related to the 2025 Notes

     

    Conference Call Details

    A conference call to discuss the second quarter 2020 financial results is scheduled for today, August 6, 2020, at 10:00 a.m. Eastern Time. The U.S. toll free dial-in for the conference call is 866-754-6931 and the international dial-in is 636-812-6625. The conference passcode is 8585726.  A live audio webcast of the conference call will be available on the “Investors” section of the Company’s website www.nationalvision.com/investors, where presentation materials will be posted prior to the conference call.

    A telephone replay will be available shortly after the broadcast through Thursday, August 13, 2020, by dialing 855-859-2056 from the U.S. or 404-537-3406 from international locations, and entering conference passcode 8585726. A replay of the audio webcast will also be archived on the “Investors” section of the Company’s website.

    About National Vision Holdings, Inc.

    National Vision Holdings, Inc. is one of the largest optical retail companies in the United States with over 1,100 retail stores in 44 states plus the District of Columbia and Puerto Rico. With a mission of helping people by making quality eyecare and eyewear more affordable and accessible, the Company operates five retail brands: America’s Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores, Vista Opticals inside select Fred Meyer stores and on select military bases, and several e-commerce websites, offering a variety of products and services for customers’ eyecare needs.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934. These statements include, but are not limited to, statements related to our current beliefs and expectations regarding the performance of our industry, the Company's strategic direction, market position, prospects and future results. You can identify these forward-looking statements by the use of words such as “outlook,” “guidance,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Caution should be taken not to place undue reliance on any forward-looking statement as such statements speak only as of the date when made. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. Forward-looking statements are not guarantees and are subject to various risks and uncertainties, which may cause actual results to differ materially from those implied in the forward-looking statements. Such factors include, but are not limited to, the scale, scope and duration of the novel coronavirus, or COVID-19, pandemic and its resurgence, and the impact of evolving federal, state, and local governmental actions in response thereto; customer behavior in response to the continuing pandemic and its resurgence, and evolving federal, state, and local governmental actions, including the impact of such behavior on in-store traffic and sales; our ability to keep our reopened stores open in a safe and cost-effective manner, or at all, in light of the continuing COVID-19 pandemic and its resurgence, and to open and operate new stores, and to successfully enter new markets in a timely and cost-effective manner; operational disruptions if a significant percentage of our workforce is unable to work or we experience labor shortages, including because of illness or travel or government restrictions in connection with the pandemic; the impact on our business of civil unrest, implementation of curfews and protests in certain locations, and related store closures or damage; our ability to recruit and retain vision care professionals for our stores in general and in light of the pandemic; our ability to develop and maintain relationships with managed vision care companies, vision insurance providers and other third-party payors; our ability to maintain the performance of our host and legacy brands and our current operating relationships with our host and legacy partners; our ability to adhere to extensive state, local and federal vision care and healthcare laws and regulations; our compliance with managed vision care laws and regulations; our ability to maintain sufficient levels of cash flow from our operations to execute or sustain our growth strategy; the loss of, or disruption in the operations of, one or more of our distribution centers and/or optical laboratories, resulting in the inability to fulfill customer orders and deliver our products in a timely manner; risks associated with vendors from whom our products are sourced, including our dependence on a limited number of suppliers; our ability to successfully compete in the highly competitive optical retail industry; any failure, inadequacy, interruption, security failure or breach of our information technology systems; our growth strategy straining our existing resources and causing the performance of our existing stores to suffer; the impact of wage rate increases, inflation, cost increases and increases in raw material prices and energy prices; our ability to successfully implement our marketing, advertising and promotional efforts; risks associated with leasing substantial amounts of space, including future increases in occupancy costs; the impact of certain technological advances, and the greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, and future drug development for the correction of vision-related problems; our ability to retain our existing senior management team and attract qualified new personnel; overall decline in the health of the economy and consumer spending affecting consumer purchases; our ability to manage our inventory balances and inventory shrinkage; seasonal fluctuations in our operating results and inventory levels; our reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of our revenues; risks associated with our e-commerce business; product liability, product recall or personal injury issues; our failure to comply with, or changes in, laws, regulations, enforcement activities and other requirements; the impact of any adverse litigation judgments or settlements resulting from legal proceedings relating to our business operations; risks of losses arising from our investments in technological innovators in the optical retail industry; our ability to adequately protect our intellectual property; our significant amount of indebtedness and our ability to generate sufficient cash flow to satisfy our significant debt service obligations; an increase in interest rates as well as changes in benchmark rates and uncertainty related to the foregoing; restrictions in our credit agreement that limits our flexibility in operating our business; and risks related to owning our common stock, including our ability to comply with requirements to design and implement and maintain effective internal controls. Additional information about these and other factors that could cause National Vision’s results to differ materially from those described in the forward-looking statements can be found in filings by National Vision with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K, our Form 8-K filed on March 19, 2020, our Quarterly Reports on Form 10-Q filed on May 7, 2020 and August 6, 2020, and subsequent filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC.

    Non-GAAP Financial Measures

    To supplement the Company’s financial information presented in accordance with GAAP and aid understanding of the Company’s business performance, the Company uses certain non-GAAP financial measures, namely “EBITDA,” “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Operating Income,” “Adjusted Operating Margin,”, “Adjusted Diluted EPS,” “Adjusted SG&A” and “Adjusted SG&A Percent of Net Revenue.” We believe EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, Adjusted SG&A and Adjusted SG&A Percent of Net Revenue assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments. Management uses these non-GAAP financial measures to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone.

    To supplement the Company’s comparable store sales growth presented in accordance with GAAP, the Company provides “Adjusted Comparable Store Sales Growth,” which is a non-GAAP financial measure we believe is useful because it provides timely and accurate information relating to the two core metrics of retail sales: number of transactions and value of transactions. Management uses Adjusted Comparable Store Sales Growth as the basis for key operating decisions, such as allocation of advertising to particular markets and implementation of special marketing programs. Accordingly, we believe that Adjusted Comparable Store Sales Growth provides timely and accurate information relating to the operational health and overall performance of each brand. We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Store Sales Growth to be meaningful.

    In the first quarter of 2020, we introduced Adjusted Operating Income and Adjusted Operating Margin as measures of performance we will use in connection with Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS. Further, consistent with our presentation of Adjusted Operating Income, we no longer exclude new store pre-opening expenses and non-cash rent from our presentation of Adjusted EBITDA and Adjusted Diluted EPS. See our Form 8-K filed with the SEC on February 26, 2020 for more information.

    Beginning with the first quarter of fiscal 2020, the Company updated its definitions of Adjusted EBITDA, Adjusted SG&A, and Adjusted Diluted EPS discussed below, so that they no longer exclude new store pre-opening expenses and non-cash rent.

    EBITDA: We define EBITDA as net income (loss), plus interest expense, income tax provision (benefit) and depreciation and amortization.

    Adjusted EBITDA: We define Adjusted EBITDA as net income (loss), plus interest expense, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expenses, and other expenses.

    Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of net revenue.

    Adjusted Operating Income: We define Adjusted Operating Income as net income (loss), plus interest expense and income tax provision (benefit), further adjusted to exclude stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, and other expenses.

    Adjusted Operating Margin: We define Adjusted Operating Margin as Adjusted Operating Income as a percentage of net revenue.

    Adjusted Diluted EPS: We define Adjusted Diluted EPS as diluted earnings (loss) per share, adjusted for the per share impact of stock compensation expense, asset impairment, litigation settlement,  management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, amortization of debt discount and deferred financing costs, losses (gains) on change in fair value of derivatives, other expenses, and tax benefit of stock option exercises, less the tax effect of these adjustments.

    Adjusted SG&A: We define Adjusted SG&A as SG&A, adjusted to exclude stock compensation expense, management realignment expenses, long-term incentive plan expenses, and other expenses except for the share of losses on equity method investments.

    Adjusted SG&A Percent of Net Revenue: We define Adjusted SG&A Percent of Net Revenue as Adjusted SG&A divided by net revenue.

    Adjusted Comparable Store Sales Growth: We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any reporting period, compared to sales recorded by the comparable store base in the prior reporting period, which we calculate as follows: (i) sales are recorded on a cash basis (i.e., when the order is placed and paid for or submitted to a managed care payor, compared to when the order is delivered), utilizing cash basis point of sale information from stores; (ii) stores are added to the calculation during the 13th full fiscal month following the store’s opening; (iii) closed stores are removed from the calculation for time periods that are not comparable; (iv) sales from partial months of operation are excluded when stores do not open or close on the first day of the month; and (v) when applicable, we adjust for the effect of the 53rd week. Quarterly, year-to-date and annual adjusted comparable store sales are aggregated using only sales from all whole months of operation included in both the current reporting period and the prior reporting period. When a partial month is excluded from the calculation, the corresponding month in the subsequent period is also excluded from the calculation. There may be variations in the way in which some of our competitors and other retailers calculate comparable store sales. As a result, our adjusted comparable store sales may not be comparable to similar data made available by other retailers. We did not adjust our calculation of Adjusted Comparable Store Sales Growth for the temporary closure of our stores to the public as a result of the COVID-19 pandemic.

    EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, Adjusted SG&A, Adjusted SG&A Percent of Net Revenue, and Adjusted Comparable Store Sales Growth are not recognized terms under GAAP and should not be considered as an alternative to net income, the ratio of net income to net revenue as a measure of financial performance, SG&A, the ratio of SG&A to net revenue as a measure of financial performance, cash flows provided by operating activities as a measure of liquidity, comparable store sales growth as a measure of operating performance, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management’s discretionary use as they do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.

    Please see “Reconciliation of Non-GAAP to GAAP Financial Measures” below for reconciliations of non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures.

     

     

    National Vision Holdings, Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets

    As of June 27, 2020 and December 28, 2019

    In Thousands, Except Par Value Information

    (Unaudited)

    ASSETS

    As of
    June 27, 2020

     

    As of
    December 28, 2019

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    256,292 

     

     

    $

    39,342 

     

    Accounts receivable, net

    58,451 

     

     

    44,475 

     

    Inventories

    117,859 

     

     

    127,556 

     

    Prepaid expenses and other current assets

    20,520 

     

     

    23,266 

     

    Total current assets

    453,122 

     

     

    234,639 

     

     

     

     

     

    Property and equipment, net

    339,905 

     

     

    366,767 

     

    Other assets:

     

     

     

    Goodwill

    777,613 

     

     

    777,613 

     

    Trademarks and trade names

    240,547 

     

     

    240,547 

     

    Other intangible assets, net

    53,236 

     

     

    56,940 

     

    Right of use assets

    341,743 

     

     

    348,090 

     

    Other assets

    12,871 

     

     

    8,129 

     

    Total non-current assets

    1,765,915 

     

     

    1,798,086 

     

    Total assets

    $

    2,219,037 

     

     

    $

    2,032,725 

     

    LIABILITIES AND STOCKHOLDERS’ EQUITY

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    52,432 

     

     

    $

    40,782 

     

    Other payables and accrued expenses

    106,865 

     

     

    82,829 

     

    Unearned revenue

    42,365 

     

     

    28,002 

     

    Deferred revenue

    51,624 

     

     

    55,870 

     

    Current maturities of long-term debt and finance lease obligations

    3,293 

     

     

    13,759 

     

    Current operating lease obligations

    55,363 

     

     

    51,937 

     

    Total current liabilities

    311,942 

     

     

    273,179 

     

     

     

     

     

    Long-term debt and finance lease obligations, less current portion and debt discount

    644,941 

     

     

    555,933 

     

    Non-current operating lease obligations

    328,453 

     

     

    331,769 

     

    Other non-current liabilities:

     

     

     

    Deferred revenue

    19,438 

     

     

    21,530 

     

    Other liabilities

    25,928 

     

     

    13,731 

     

    Deferred income taxes, net

    67,396 

     

     

    60,146 

     

    Total other non-current liabilities

    112,762 

     

     

    95,407 

     

    Commitments and contingencies (See Note 9)

     

     

     

    Stockholders’ equity:

     

     

     

    Common stock, $0.01 par value; 200,000 shares authorized; 81,342 and 80,603 shares issued as of June 27, 2020 and December 28, 2019, respectively; 80,415 and 79,678 shares outstanding as of June 27, 2020 and December 28, 2019, respectively

    812 

     

     

    805 

     

    Additional paid-in capital

    782,851 

     

     

    700,121 

     

    Accumulated other comprehensive loss

    (7,355)

     

     

    (3,814)

     

    Retained earnings

    72,512 

     

     

    107,132 

     

    Treasury stock, at cost; 927 and 925 shares as of June 27, 2020 and December 28, 2019, respectively

    (27,881)

     

     

    (27,807)

     

    Total stockholders’ equity

    820,939 

     

     

    776,437 

     

    Total liabilities and stockholders’ equity

    $

    2,219,037 

     

     

    $

    2,032,725 

     

    National Vision Holdings, Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations and Comprehensive Income

    For the Three and Six Months Ended June 27, 2020 and June 29, 2019

    In Thousands, Except Earnings Per Share

    (Unaudited)

     

    Three Months Ended

     

    Six Months Ended

     

    June 27, 2020

     

    June 29, 2019

     

    June 27, 2020

     

    June 29, 2019

    Revenue:

     

     

     

     

     

     

     

    Net product sales

    $

    209,707 

     

     

    $

    357,533 

     

     

    $

    602,548 

     

     

    $

    740,693 

     

    Net sales of services and plans

    50,300 

     

     

    71,918 

     

     

    127,163 

     

     

    149,973 

     

    Total net revenue

    260,007 

     

     

    429,451 

     

     

    729,711 

     

     

    890,666 

     

    Costs applicable to revenue (exclusive of depreciation and amortization):

     

     

     

     

     

     

     

    Products

    97,635 

     

     

    145,654 

     

     

    254,005 

     

     

    299,658 

     

    Services and plans

    43,145 

     

     

    56,852 

     

     

    105,329 

     

     

    114,817 

     

    Total costs applicable to revenue

    140,780 

     

     

    202,506 

     

     

    359,334 

     

     

    414,475 

     

    Operating expenses:

     

     

     

     

     

     

     

    Selling, general and administrative expenses

    136,582 

     

     

    182,278 

     

     

    330,323 

     

     

    376,154 

     

    Depreciation and amortization

    21,924 

     

     

    20,819 

     

     

    46,734 

     

     

    41,234 

     

    Asset impairment

    2,411 

     

     

    1,790 

     

     

    13,766 

     

     

    3,872 

     

    Litigation settlement

    — 

     

     

    — 

     

     

    4,395 

     

     

    — 

     

    Other expense (income), net

    (92)

     

     

    356 

     

     

    (158)

     

     

    829 

     

    Total operating expenses

    160,825 

     

     

    205,243 

     

     

    395,060 

     

     

    422,089 

     

    Income (loss) from operations

    (41,598)

     

     

    21,702 

     

     

    (24,683)

     

     

    54,102 

     

    Interest expense, net

    15,502 

     

     

    8,968 

     

     

    22,957 

     

     

    18,029 

     

    Debt issuance costs

    136 

     

     

    — 

     

     

    136 

     

     

    — 

     

    Earnings (loss) before income taxes

    (57,236)

     

     

    12,734 

     

     

    (47,776)

     

     

    36,073 

     

    Income tax provision (benefit)

    (13,403)

     

     

    2,477 

     

     

    (13,685)

     

     

    8,387 

     

    Net income (loss)

    $

    (43,833)

     

     

    $

    10,257 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

     

     

     

     

     

     

     

     

    Earnings (loss) per share:

     

     

     

     

     

     

     

    Basic

    $

    (0.55)

     

     

    $

    0.13 

     

     

    $

    (0.42)

     

     

    $

    0.35 

     

    Diluted

    $

    (0.55)

     

     

    $

    0.13 

     

     

    $

    (0.42)

     

     

    $

    0.34 

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

    Basic

    80,325 

     

     

    78,318 

     

     

    80,226 

     

     

    78,262 

     

    Diluted

    80,325 

     

     

    81,424 

     

     

    80,226 

     

     

    81,437 

     

     

     

     

     

     

     

     

     

    Comprehensive income (loss):

     

     

     

     

     

     

     

    Net income (loss)

    $

    (43,833)

     

     

    $

    10,257 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

    Unrealized gain (loss) on hedge instruments

    4,111 

     

     

    (2,246)

     

     

    (4,747)

     

     

    (3,519)

     

    Tax provision (benefit) of unrealized gain (loss) on hedge instruments

    1,050 

     

     

    (576)

     

     

    (1,206)

     

     

    (902)

     

    Comprehensive income (loss)

    $

    (40,772)

     

     

    $

    8,587 

     

     

    $

    (37,632)

     

     

    $

    25,069 

     

     

     

     

     

    National Vision Holdings, Inc. and Subsidiaries

    Condensed Consolidated Statements of Cash Flows

    For the Six Months Ended June 27, 2020 and June 29, 2019

    In Thousands

    (Unaudited)

     

    Six Months Ended

     

    June 27, 2020

     

    June 29, 2019

    Cash flows from operating activities:

     

     

     

    Net income (loss)

    $

    (34,091)

     

     

    $

    27,686 

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation and amortization

    46,734 

     

     

    41,234 

     

    Amortization of debt discount and deferred financing costs

    2,717 

     

     

    892 

     

    Asset impairment

    13,766 

     

     

    3,872 

     

    Deferred income tax expense (benefit)

    (13,686)

     

     

    8,239 

     

    Stock based compensation expense

    5,445 

     

     

    4,717 

     

    Losses (gains) on change in fair value of derivatives

    4,871 

     

     

    — 

     

    Inventory adjustments

    2,883 

     

     

    2,043 

     

    Credit loss expense

    432 

     

     

    3,865 

     

    Other

    1,373 

     

     

    1,592 

     

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable

    (14,408)

     

     

    (10,567)

     

    Inventories

    6,814 

     

     

    8,319 

     

    Other assets

    3,444 

     

     

    11,391 

     

    Accounts payable

    11,630 

     

     

    3,458 

     

    Deferred revenue

    (6,338)

     

     

    5,804 

     

    Other liabilities

    39,834 

     

     

    6,734 

     

    Net cash provided by operating activities

    71,420 

     

     

    119,279 

     

    Cash flows from investing activities:

     

     

     

    Purchase of property and equipment

    (25,796)

     

     

    (52,103)

     

    Other

    265 

     

     

    315 

     

    Net cash used for investing activities

    (25,531)

     

     

    (51,788)

     

    Cash flows from financing activities:

     

     

     

    Borrowings on long-term debt, net of discounts

    548,769 

     

     

    — 

     

    Repayments on long-term debt

    (369,269)

     

     

    (2,500)

     

    Proceeds from exercise of stock options

    5,998 

     

     

    2,066 

     

    Purchase of treasury stock

    (74)

     

     

    — 

     

    Payments of debt issuance costs

    (12,400)

     

     

    — 

     

    Payments on finance lease obligations

    (1,587)

     

     

    (1,190)

     

    Net cash provided by (used for) financing activities

    171,437 

     

     

    (1,624)

     

    Net change in cash, cash equivalents and restricted cash

    217,326 

     

     

    65,867 

     

    Cash, cash equivalents and restricted cash, beginning of year

    40,307 

     

     

    17,998 

     

    Cash, cash equivalents and restricted cash, end of period

    $

    257,633 

     

     

    $

    83,865 

     

     

     

     

     

    Supplemental cash flow disclosure information:

     

     

     

    Cash paid for interest

    $

    13,810 

     

     

    $

    17,438 

     

    Capital expenditures accrued at the end of the period

    $

    11,265 

     

     

    $

    22,033 

     

    Right of use assets acquired under finance leases

    $

    1,257 

     

     

    $

    9,763 

     

    Right of use assets acquired under operating leases

    $

    35,870 

     

     

    $

    58,528 

     

     

     

    National Vision Holdings, Inc. and Subsidiaries

    Reconciliation of Non-GAAP to GAAP Financial Measures

    For the Three and Six Months Ended June 27, 2020 and June 29, 2019

    In Thousands, Except Per Share Information

    (Unaudited)

    Reconciliation of Adjusted Operating Income to Net Income

     

     

    Three Months Ended

     

    Six Months Ended

     

    In thousands

    June 27, 2020

     

    June 29, 2019

     

    June 27, 2020

     

    June 29, 2019

     

    Net income (loss)

    $

    (43,833)

     

    (16.9)%

     

    $

    10,257 

     

    2.4%

     

    $

    (34,091)

     

    (4.7)%

     

    $

    27,686 

     

    3.1%

    Interest expense

    15,502 

     

    6.0%

     

    8,968 

     

    2.1%

     

    22,957 

     

    3.1%

     

    18,029 

     

    2.0%

     

    Income tax provision (benefit)

    (13,403)

     

    (5.2)%

     

    2,477 

     

    0.6%

     

    (13,685)

     

    (1.9)%

     

    8,387 

     

    0.9%

     

    Stock compensation expense (a)

    3,352 

     

    1.3%

     

    1,741 

     

    0.4%

     

    5,445 

     

    0.7%

     

    4,717 

     

    0.5%

     

    Asset impairment (b)

    2,411 

     

    0.9%

     

    1,790 

     

    0.4%

     

    13,766 

     

    1.9%

     

    3,872 

     

    0.4%

     

    Litigation settlement (c)

    — 

     

    —%

     

    — 

     

    —%

     

    4,395 

     

    0.6%

     

    — 

     

    —%

     

    Management realignment expenses (d)

    — 

     

    —%

     

    — 

     

    —%

     

    — 

     

    —%

     

    2,155 

     

    0.2%

     

    Long-term incentive plan (e)

    — 

     

    —%

     

    781 

     

    0.2%

     

    — 

     

    —%

     

    722 

     

    0.1%

     

    Amortization of acquisition intangibles (f)

    1,851 

     

    0.7%

     

    1,851 

     

    0.4%

     

    3,702 

     

    0.5%

     

    3,702 

     

    0.4%

     

    Other (i)

    (307)

     

    (0.1)%

     

    1,223 

     

    0.3%

     

    1,149 

     

    0.2%

     

    2,467 

     

    0.3%

     

    Adjusted Operating Income / Adjusted Operating Margin

    $

    (34,427)

     

    (13.2)%

     

    $

    29,088 

     

    6.8%

     

    $

    3,638 

     

    0.5%

     

    $

    71,737 

     

    8.1%

     Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding.

     Some of the percentage totals in the table above do not foot due to rounding differences.

     

     

     

     

     

    Reconciliation of EBITDA and Adjusted EBITDA to Net Income

     

     

    Three Months Ended

     

    Six Months Ended

     

    In thousands

    June 27, 2020

     

    June 29, 2019

     

    June 27, 2020

     

    June 29, 2019

     

    Net income (loss)

    $

    (43,833)

     

    (16.9)%

     

    $

    10,257 

     

    2.4%

     

    $

    (34,091)

     

    (4.7)%

     

    $

    27,686 

     

    3.1%

    Interest expense

    15,502 

     

    6.0%

     

    8,968 

     

    2.1%

     

    22,957 

     

    3.1%

     

    18,029 

     

    2.0%

     

    Income tax provision (benefit)

    (13,403)

     

    (5.2)%

     

    2,477 

     

    0.6%

     

    (13,685)

     

    (1.9)%

     

    8,387 

     

    0.9%

     

    Depreciation and amortization

    21,924 

     

    8.4%

     

    20,819 

     

    4.8%

     

    46,734 

     

    6.4%

     

    41,234 

     

    4.6%

     

    EBITDA

    (19,810)

     

    (7.6)%

     

    42,521 

     

    9.9%

     

    21,915 

     

    3.0%

     

    95,336 

     

    10.7%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Stock compensation expense (a)

    3,352 

     

    1.3%

     

    1,741 

     

    0.4%

     

    5,445 

     

    0.7%

     

    4,717 

     

    0.5%

     

    Asset impairment (b)

    2,411 

     

    0.9%

     

    1,790 

     

    0.4%

     

    13,766 

     

    1.9%

     

    3,872 

     

    0.4%

     

    Litigation settlement (c)

    — 

     

    —%

     

    — 

     

    —%

     

    4,395 

     

    0.6%

     

    — 

     

    —%

     

    Management realignment expenses (d)

    — 

     

    —%

     

    — 

     

    —%

     

    — 

     

    —%

     

    2,155 

     

    0.2%

     

    Long-term incentive plan (e)

    — 

     

    —%

     

    781 

     

    0.2%

     

    — 

     

    —%

     

    722 

     

    0.1%

     

    Other (i)

    (307)

     

    (0.1)%

     

    1,223 

     

    0.3%

     

    1,149 

     

    0.2%

     

    2,467 

     

    0.3%

     

    Adjusted EBITDA / Adjusted EBITDA Margin

    $

    (14,354)

     

    (5.5)%

     

    $

    48,056 

     

    11.2%

     

    $

    46,670 

     

    6.4%

     

    $

    109,269 

     

    12.3%

     Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding.
     Some of the percentage totals in the table above do not foot due to rounding differences

     

                                                                         

     

     

    Reconciliation of Adjusted Diluted EPS to Diluted EPS

     

     

    Three Months Ended

     

    Six Months Ended

     

    In thousands, except per share amounts

    June 27, 2020

     

    June 29, 2019

     

    June 27, 2020

     

    June 29, 2019

     

    Diluted EPS

    $

    (0.55)

     

     

    $

    0.13 

     

     

    $

    (0.42)

     

     

    $

    0.34 

     

    Stock compensation expense (a)

    0.04 

     

     

    0.02 

     

     

    0.07 

     

     

    0.06 

     

     

    Asset impairment (b)

    0.03 

     

     

    0.02 

     

     

    0.17 

     

     

    0.05 

     

     

    Litigation settlement (c)

    — 

     

     

    — 

     

     

    0.05 

     

     

    — 

     

     

    Management realignment expenses (d)

    — 

     

     

    — 

     

     

    — 

     

     

    0.03 

     

     

    Long-term incentive plan (e)

    — 

     

     

    0.01 

     

     

    — 

     

     

    0.01 

     

     

    Amortization of acquisition intangibles (f)

    0.02 

     

     

    0.02 

     

     

    0.05 

     

     

    0.05 

     

     

    Amortization of debt discount and deferred financing costs (g)

    0.03 

     

     

    0.01 

     

     

    0.03 

     

     

    0.01 

     

     

    Losses (gains) on change in fair value of derivatives (h)

    0.06 

     

     

    — 

     

     

    0.06 

     

     

    — 

     

     

    Other (i)

    — 

     

     

    0.02 

     

     

    0.01 

     

     

    0.03 

     

     

    Tax benefit of stock option exercises (j)

    — 

     

     

    (0.01)

     

     

    (0.04)

     

     

    (0.02)

     

     

    Tax effect of total adjustments (k)

    (0.05)

     

     

    (0.02)

     

     

    (0.12)

     

     

    (0.06)

     

     

    Adjusted Diluted EPS

    $

    (0.41)

     

     

    $

    0.18 

     

     

    $

    (0.13)

     

     

    $

    0.49 

     

     

     

     

     

     

     

     

     

     

    Weighted average diluted shares outstanding

    80,325 

     

     

    81,424 

     

     

    80,226 

     

     

    81,437 

     

     

    Note: Some of the totals in the table above do not foot due to rounding differences

     

     

     

    Reconciliation of Adjusted SG&A and Adjusted SG&A Percent of Net Revenue to SG&A

     

     

    Three Months Ended

     

    Six Months Ended

     

    In thousands

    June 27, 2020

     

    June 29, 2019

     

    June 27, 2020

     

    June 29, 2019

     

    SG&A

    $

    136,582 

     

    52.5%

     

    $

    182,278 

     

    42.4%

     

    $

    330,323 

     

    45.3%

     

    $

    376,154 

     

    42.2%

                                                                                                                     

    Stock compensation expense (a)

    3,352 

     

    1.3%

     

    1,741 

     

    0.4%

     

    5,445 

     

    0.7%

     

    4,717 

     

    0.5%

     

    Management realignment expenses (d)

    — 

     

    —%

     

    — 

     

    —%

     

    — 

     

    —%

     

    2,155 

     

    0.2%

     

    Long-term incentive plan (e)

    — 

     

    —%

     

    781 

     

    0.2%

     

    — 

     

    —%

     

    722 

     

    0.1%

     

    Other (l)

    (307)

     

    (0.1)%

     

    776 

     

    0.2%

     

    1,149 

     

    0.2%

     

    1,460 

     

    0.2%

     

    Adjusted SG&A/ Adjusted SG&A Percent of Net Revenue

    $

    133,537 

     

    51.4%

     

    $

    178,980 

     

    41.7%

     

    $

    323,729 

     

    44.4%

     

    $

    367,100 

     

    41.2%

    Note: Percentages reflect line item as a percentage of net revenue.

    Some of the percentage totals in the table above do not foot due to rounding differences.

     

                                                                         

     

    • Non-cash charges related to stock-based compensation programs, which vary from period to period depending on the timing of awards and performance vesting conditions.
    • Reflects write-off of property, equipment and lease related assets on closed or underperforming stores.
    • Expenses associated with settlement of litigation. See Note 9. “Commitments and Contingencies” for further details.
    • Expenses related to a non-recurring management realignment described in the Current Report on Form 8-K filed with the SEC on January 10, 2019.
    • Expenses pursuant to a long-term incentive plan for non-executive employees who were not participants in the management equity plan for fiscal year 2019. This plan was effective in 2014 following the acquisition of the Company by affiliates of KKR & Co. Inc. (the "KKR Acquisition").
    • Amortization of the increase in carrying values of finite-lived intangible assets resulting from the application of purchase accounting to the KKR Acquisition.
    • Amortization of debt discount is associated with the amortization of the conversion feature related to the convertible notes and amortization of deferred financing costs relate to the convertible note, term loan and revolving credit facility borrowings. Amortization of debt discount and deferred financing costs in aggregate total $2.5 million and $0.5 million for the three months ended June 27, 2020 and June 29, 2019, respectively, and $2.7 million and $0.9 million for the six months ended June 27, 2020 and June 29, 2019, respectively.
    • Reflects $4.9 million of losses recognized in interest expense on change in fair value of de-designated hedges for the three and six months ended June 27, 2020.
    • Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA), including our share of losses on equity method investments of $0.4 million for the three months ended June 29, 2019 and $1.0 million for the six months ended June 29, 2019; the amortization impact of adjustments related to the KKR Acquisition, (e.g., fair value of leasehold interests) of $0.1 million for each of the three months ended June 27, 2020 and June 29, 2019, respectively, and $0.2 million for each of the six months ended June 27, 2020 and June 29, 2019, respectively; costs of severance and relocation of $0.2 million and $0.6 million for the three months ended June 27, 2020 and June 29, 2019, respectively, and $0.5 million and $0.8 million for the six months ended June 27, 2020 and June 29, 2019, respectively; excess payroll taxes related to stock option exercises of $0.1 million for the three months ended June 29, 2019, and $0.3 million and $0.1 million for the six months ended June 27, 2020 and June 29, 2019, respectively; incremental costs directly related to adapting the Company’s operations during the COVID-19 pandemic of $0.6 million for the six months ended June 27, 2020; and other expenses and adjustments totaling $(0.7) million and $(31) thousand for the three months ended June 27, 2020 and June 29, 2019, respectively, and $(0.5) million and $0.3 million for the six months ended June 27, 2020 and June 29, 2019, respectively.
    • Tax benefit associated with accounting guidance requiring excess tax benefits related to stock option exercises to be recorded in earnings as discrete items in the reporting period in which they occur.
    • Represents the income tax effect of the total adjustments at our combined statutory federal and state income tax rates.
    • Reflects other expenses in (i) above, except for our share of losses on equity method investments of $0.4 million for the three months ended June 29, 2019 and $1.0 million for the six months ended June 29, 2019, respectively.

     

    Reconciliation of Adjusted Comparable Store Sales Growth to Total Comparable Store Sales Growth

     

    Comparable store sales growth(a)

     

    Three Months Ended

     

    Six Months Ended

     

    June 27, 2020

     

    June 29, 2019

     

    June 27, 2020

     

    June 29, 2019

    Owned & Host segment

     

     

     

     

     

     

     

    America’s Best

    (37.1)

    %

     

    4.5 

    %

     

    (22.2)

    %

     

    6.4 

    %

    Eyeglass World

    (31.6)

    %

     

    5.2 

    %

     

    (21.2)

    %

     

    5.9 

    %

    Military

    (44.6)

    %

     

    0.3 

    %

     

    (27.8)

    %

     

    (2.2)

    %

    Fred Meyer

    (48.6)

    %

     

    (5.3)

    %

     

    (32.5)

    %

     

    (7.5)

    %

    Legacy segment

    (35.8)

    %

     

    0.4 

    %

     

    (24.4)

    %

     

    1.1 

    %

     

     

     

     

     

     

     

     

    Total comparable store sales growth

    (44.7)

    %

     

    4.4 

    %

     

    (23.0)

    %

     

    5.4 

    %

    Adjusted Comparable Store Sales Growth(b)

    (36.5)

    %

     

    3.8 

    %

     

    (22.6)

    %

     

    5.3 

    %

     

     

     

     

     

     

     

     

    Additional Comparable Store Sales
    Growth information for Q2 2020

     

     

    One Month Ended
    April 25, 2020

     

    One Month Ended
    May 30, 2020

     

    One Month Ended
    June 27, 2020

    Total comparable store sales growth

     

     

    (83.9)

    %

     

    (56.6)

    %

     

    14.3 

    %

    Adjusted Comparable Store Sales Growth(b)

     

     

    (86.6)

    %

     

    (38.5)

    %

     

    19.3 

    %

    • Total comparable store sales based on consolidated net revenue excluding the impact of (i) Corporate/Other segment net revenue, (ii) sales from stores opened less than 13 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month and (v) if applicable, the impact of a 53rd week in a fiscal year. Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 10. “Segment Reporting” in our unaudited condensed consolidated financial statements included in Part 1. Item 1. in our Quarterly Report on Form 10-Q, with the exception of the Legacy segment, which is adjusted as noted in clause (b) (ii) below.
    • There are two differences between total comparable store sales growth based on consolidated net revenue and Adjusted Comparable Store Sales Growth: (i) Adjusted Comparable Store Sales Growth includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in the following changes from total comparable store sales growth based on consolidated net revenue: an increase of 8.1% and a decrease of 0.4% for the three months ended June 27, 2020 and June 29, 2019, respectively, an increase of 0.3% and an increase of 0.2% for the six months ended June 27, 2020 and June 29, 2019, respectively, a decrease of 3.3% for the one month ended April 25, 2020, an increase of 17.7% for the one month ended May 30, 2020, and an increase of 6.0% for the one month ended June 27, 2020; and (ii) Adjusted Comparable Store Sales Growth includes retail sales to the Legacy partner’s customers (rather than the revenues recognized consistent with the management & services agreement with the legacy partner), resulting the following changes from total comparable store sales growth based on consolidated net revenue: an increase of 0.1% and a decrease of 0.2% for three months ended June 27, 2020 and June 29, 2019, respectively, an increase of 0.1% and a decrease of 0.3% for the six months ended June 27, 2020 and June 29, 2019, respectively, an increase of 0.6% for the one month ended April 25, 2020, an increase of 0.4% for the one month ended May 30, 2020, and a decrease of 1.0% for the one month ended June 27, 2020.

     

     


    Investors:

     

    National Vision Holdings, Inc.

    David Mann, CFA, Vice President of Investor Relations

    (470) 448-2448

    [email protected]

     

    Media:

     

    National Vision Holdings, Inc.

    Kristina Gross, Vice President of Communications

    (470) 448-2355

    [email protected]

    Twitter

    Twitter

    Facebook

    Facebook

    LinkedIn

    LinkedIn

    YouTube

    YouTube

    Blog

    Blog